355 related articles for article (PubMed ID: 30522515)
1. The risks of cancer development in systemic lupus erythematosus (SLE) patients: a systematic review and meta-analysis.
Song L; Wang Y; Zhang J; Song N; Xu X; Lu Y
Arthritis Res Ther; 2018 Dec; 20(1):270. PubMed ID: 30522515
[TBL] [Abstract][Full Text] [Related]
2. Systemic lupus erythematous and malignancy risk: a meta-analysis.
Cao L; Tong H; Xu G; Liu P; Meng H; Wang J; Zhao X; Tang Y; Jin J
PLoS One; 2015; 10(4):e0122964. PubMed ID: 25885411
[TBL] [Abstract][Full Text] [Related]
3. Association Between Systemic Lupus Erythematosus and Cancer Morbidity and Mortality: Findings From Cohort Studies.
Zhang M; Wang Y; Wang Y; Bai Y; Gu D
Front Oncol; 2022; 12():860794. PubMed ID: 35600353
[TBL] [Abstract][Full Text] [Related]
4. Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis.
Ni J; Qiu LJ; Hu LF; Cen H; Zhang M; Wen PF; Wang XS; Pan HF; Ye DQ
Lupus; 2014 Mar; 23(3):284-92. PubMed ID: 24429300
[TBL] [Abstract][Full Text] [Related]
5. No association between the risk of breast cancer and systemic lupus erythematosus: evidence from a meta-analysis.
Rezaieyazdi Z; Tabaei S; Ravanshad Y; Akhtari J; Mehrad-Majd H
Clin Rheumatol; 2018 Jun; 37(6):1511-1519. PubMed ID: 29294194
[TBL] [Abstract][Full Text] [Related]
6. Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: A Danish nationwide cohort study.
Westermann R; Zobbe K; Cordtz R; Haugaard JH; Dreyer L
Lupus; 2021 Apr; 30(5):752-761. PubMed ID: 33497306
[TBL] [Abstract][Full Text] [Related]
7. Vaccinations and risk of systemic lupus erythematosus and rheumatoid arthritis: A systematic review and meta-analysis.
Wang B; Shao X; Wang D; Xu D; Zhang JA
Autoimmun Rev; 2017 Jul; 16(7):756-765. PubMed ID: 28483543
[TBL] [Abstract][Full Text] [Related]
8. Thyroid cancer in systemic lupus erythematosus: a meta analysis.
Zhang M; Li XM; Wang GS; Qian L; Tao JH; Ma Y; Li XP
Int J Clin Exp Pathol; 2014; 7(9):6270-3. PubMed ID: 25337279
[TBL] [Abstract][Full Text] [Related]
9. Risk of malignancy in patients with systemic lupus erythematosus: Systematic review and meta-analysis.
Clarke AE; Pooley N; Marjenberg Z; Langham J; Nicholson L; Langham S; Embleton N; Wang X; Desta B; Barut V; Hammond ER
Semin Arthritis Rheum; 2021 Dec; 51(6):1230-1241. PubMed ID: 34710720
[TBL] [Abstract][Full Text] [Related]
10. Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California.
Parikh-Patel A; White RH; Allen M; Cress R
Cancer Causes Control; 2008 Oct; 19(8):887-94. PubMed ID: 18386139
[TBL] [Abstract][Full Text] [Related]
11. Risk of pancreatic cancer in patients with systemic lupus erythematosus: a meta-analysis.
Seo MS; Yeo J; Hwang IC; Shim JY
Clin Rheumatol; 2019 Nov; 38(11):3109-3116. PubMed ID: 31270697
[TBL] [Abstract][Full Text] [Related]
12. A systematic review of the epidemiological literature on the risk of urological cancers in systemic lupus erythematosus.
Huang HB; Jiang SC; Han J; Cheng QS; Dong CB; Pan CM
J Cancer Res Clin Oncol; 2014 Jul; 140(7):1067-73. PubMed ID: 24525705
[TBL] [Abstract][Full Text] [Related]
13. Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus.
Mellemkjaer L; Andersen V; Linet MS; Gridley G; Hoover R; Olsen JH
Arthritis Rheum; 1997 Apr; 40(4):761-8. PubMed ID: 9125261
[TBL] [Abstract][Full Text] [Related]
14. An international cohort study of cancer in systemic lupus erythematosus.
Bernatsky S; Boivin JF; Joseph L; Rajan R; Zoma A; Manzi S; Ginzler E; Urowitz M; Gladman D; Fortin PR; Petri M; Edworthy S; Barr S; Gordon C; Bae SC; Sibley J; Isenberg D; Rahman A; Aranow C; Dooley MA; Steinsson K; Nived O; Sturfelt G; Alarcón G; Senécal JL; Zummer M; Hanly J; Ensworth S; Pope J; El-Gabalawy H; McCarthy T; St Pierre Y; Ramsey-Goldman R; Clarke A
Arthritis Rheum; 2005 May; 52(5):1481-90. PubMed ID: 15880596
[TBL] [Abstract][Full Text] [Related]
15. Allergic rhinitis and risk of systemic lupus erythematosus: A systematic review and meta-analysis.
Wongtrakul W; Charoenngam N; Ponvilawan B; Ungprasert P
Int J Rheum Dis; 2020 Nov; 23(11):1460-1467. PubMed ID: 32749784
[TBL] [Abstract][Full Text] [Related]
16. An Updated Meta-analysis on the Risk of Urologic Cancer in Patients with Systemic Lupus Erythematosus.
Yeo J; Seo MS; Hwang IC; Shim JY
Arch Iran Med; 2020 Sep; 23(9):614-620. PubMed ID: 32979908
[TBL] [Abstract][Full Text] [Related]
17. Malignancy in systemic lupus erythematosus.
Abu-Shakra M; Gladman DD; Urowitz MB
Arthritis Rheum; 1996 Jun; 39(6):1050-4. PubMed ID: 8651970
[TBL] [Abstract][Full Text] [Related]
18. Predictors of cardiovascular events in patients with systemic lupus erythematosus (SLE): a systematic review and meta-analysis.
Ballocca F; D'Ascenzo F; Moretti C; Omedè P; Cerrato E; Barbero U; Abbate A; Bertero MT; Zoccai GB; Gaita F
Eur J Prev Cardiol; 2015 Nov; 22(11):1435-41. PubMed ID: 25139772
[TBL] [Abstract][Full Text] [Related]
19. Systemic lupus erythematosus and malignancies risk.
Mao S; Shen H; Zhang J
J Cancer Res Clin Oncol; 2016 Jan; 142(1):253-62. PubMed ID: 26319223
[TBL] [Abstract][Full Text] [Related]
20. Thrombocytopenia as a Prognostic Marker for Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis.
Chen Z; Zhong H; Dong G
Am J Med Sci; 2019 Jun; 357(6):461-467. PubMed ID: 30987767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
